v3.26.1
STOCKHOLDERS’ EQUITY - Narrative (Details)
$ / shares in Units, $ in Thousands
6 Months Ended 12 Months Ended
Jul. 01, 2026
shares
Sep. 18, 2025
USD ($)
$ / shares
Jul. 01, 2025
$ / shares
Jun. 12, 2024
shares
Feb. 21, 2024
USD ($)
$ / shares
shares
Feb. 15, 2024
Jun. 30, 2026
$ / shares
shares
Dec. 31, 2024
USD ($)
shares
Jan. 12, 2026
$ / shares
shares
Dec. 31, 2025
$ / shares
Apr. 16, 2025
shares
Jul. 26, 2024
USD ($)
Jun. 11, 2024
shares
Subsidiary, Sale of Stock [Line Items]                          
Stock split, conversion ratio     0.1     0.11 0.10            
Common stock, increase (decrease) in capital shares reserved for future issuance (in shares)       150,000                  
Common shares authorized (in shares)       194,444             2,400,000   44,444
Number of shares available for grant (in shares)             395,272            
Common stock, par value (in dollars per share) | $ / shares     $ 0.0001       $ 0.0001   $ 0.0001 $ 0.0001      
Stock options | Two Thousand Twenty Three Plan                          
Subsidiary, Sale of Stock [Line Items]                          
Stock options expiration period             10 years            
Performance Shares | Subsequent Event                          
Subsidiary, Sale of Stock [Line Items]                          
Granted (in shares) 179,050                        
Underwriter Warrants                          
Subsidiary, Sale of Stock [Line Items]                          
Number of securities called by warrants (in shares)             5,500            
Warrant exercise price (in dollars per share) | $ / shares             $ 33.31            
Horizon Warrants                          
Subsidiary, Sale of Stock [Line Items]                          
Number of securities called by warrants (in shares)             65,488   65,488        
Warrant exercise price (in dollars per share) | $ / shares             $ 27.49   $ 27.49        
Warrant term                 10 years        
IPO                          
Subsidiary, Sale of Stock [Line Items]                          
Sale of stock, number of shares issued in transaction (in shares)         110,000                
Sale of preferred stock price per share (in dollars per share) | $ / shares         $ 60.00                
Proceeds from issuance initial public offering | $         $ 5,900                
Offering cost, expense | $         $ 900                
IPO | Underwriter Warrants                          
Subsidiary, Sale of Stock [Line Items]                          
Number of securities called by warrants (in shares)         5,500                
Warrant exercise price (in dollars per share) | $ / shares   $ 33.31     $ 75.00                
Warrant, period following commencement date, exercisable         180 days                
Fair value adjustment of warrants | $   $ 31                      
CEF Purchase Agreement                          
Subsidiary, Sale of Stock [Line Items]                          
Sale of stock, number of shares issued in transaction (in shares)               15,597          
Sale of stock, authorized amount | $                       $ 30,000  
Sale of stock, consideration received on transaction | $               $ 109